4 Ways Vaccine Skeptics Mislead You on Measles and More
By Amy Maxmen and Céline Gounder
May 22, 2024
KFF Health News Original
Vaccine scare tactics haven’t shifted, but more parents are falling for them. Here’s what the rhetoric gets wrong and how it endangers children.
California Pays Meth Users To Get Sober
By Angela Hart
May 22, 2024
KFF Health News Original
California’s Medicaid program is testing a novel approach for people addicted to methamphetamine, cocaine, and other stimulants. For every clean urine test, they can earn money — up to $599 a year.
He Fell Ill on a Cruise. Before He Boarded the Rescue Boat, They Handed Him the Bill.
By Bram Sable-Smith
May 22, 2024
KFF Health News Original
A man from Michigan was evacuated from a cruise ship after having seizures. First, he drained his bank account to pay his medical bills.
Exclusive: Senator Urges Biden Administration To Thwart Fraudulent Obamacare Enrollments
By Julie Appleby
May 21, 2024
KFF Health News Original
With tens of thousands of Americans already affected by enrollment scams that leave some without doctors or treatments, Oregon Sen. Ron Wyden wants increased enforcement against rogue agents or other perpetrators and legislation to allow for criminal penalties.
I Was There When Bird Flu First Appeared. It’s Different Today.
By Elisabeth Rosenthal
May 21, 2024
KFF Health News Original
The H5N1 flu virus and I go way back. In 1997, I watched as more than a million chickens were slaughtered in Hong Kong to combat the first major global outbreak of the disease. Eighteen people were sickened by the virus and six died, all of whom had close contact with the birds. They were […]
UnitedHealth Teases New Value-Based Drug Pricing Model Coming In 2025
May 21, 2024
Morning Briefing
UnitedHealth’s OptumRx Clear Trend Guarantee is designed to help manage insurers’ costs for drugs, Reuters says. Under value-based models like this, everyone in the supply chain agrees to link payments for the drugs to the patient’s outcome.
988 Helpline Has Helped 10 Million People In Crisis Since Launch
May 21, 2024
Morning Briefing
The Boston Globe pays particular attention to Rhode Island, where over 33,000 calls have been answered, which has the country’s highest in-state answer rate. The hotline was launched in 2022.
Study Links Higher Fluoride Exposure In Pregnancy To Kids’ Behavior Issues
May 21, 2024
Morning Briefing
Also in the news: More seniors are making ER visits as legalized weed is approved in more places; a major study found that weed use by minors was lower in states where the drug was legal; paralysis treatment from a novel spinal cord stimulator; and more.
Viewpoints: US Policies Hinder Needed Immigrant Doctors; Here’s How PCPs Hope To Collaborate With AI
May 21, 2024
Morning Briefing
Editorial writers tackle immigrant doctors, AI in health care, mental health, and more.
Over 1 Million Claims Granted Under PACT Act For Vets Exposed To Toxins
May 21, 2024
Morning Briefing
The White House released the latest numbers related to 2022 PACT Act, which provides compensation and disability benefits for veterans who were sickened by toxic materials during their service. More claims are also in the works, with 4.17 million submitted over the past two years.
Bird Flu Spreads To Three Dairy Herds In Michigan, Cats In South Dakota
May 21, 2024
Morning Briefing
In a scientific breakthrough, researchers have developed a full genetic sequence of the H5N1 virus from milk. With this new information, they say they can better monitor the progression of the disease in dairy cattle.
Visiting Saudi Arabia? Be Sure To Get Meningococcal Vaccine First, CDC Says
May 21, 2024
Morning Briefing
Twelve cases stemming from people who either traveled to the nation or were close contacts prompted the travel and health alerts. In other news, a more severe mpox outbreak in the Democratic Republic of the Congo could have global implications.
Doctors Say Texas’ Emergency Abortion Rules Will Only Increase Confusion
May 21, 2024
Morning Briefing
During a public hearing Monday, physicians and lawyers said the medical board’s rules don’t answer critical questions such as “how close to death a patient needs to be” before a doctor can intervene.
Health Officials To Unveil $50 Million Program To Beat Cyberattacks
May 21, 2024
Morning Briefing
The effort will create tools to defend net-connected private hospitals from cyberattacks like the recent Ascension and Change Health hacks — the effects of which are still reverberating, with cybersecurity experts reportedly on “edge” and looking for system weaknesses.
Morning Briefing for Tuesday, May 21, 2024
May 21, 2024
Morning Briefing
High prices of diabetes drugs, PACT Act claims, bird flu, abortion access, cyberattacks, 988 helpline, the election, and more are in the news.
First Edition: May 21, 2024
May 21, 2024
Morning Briefing
Today’s early morning highlights from the major news organizations.
Watch: Medical Residents Are Increasingly Avoiding Abortion Ban States
May 21, 2024
KFF Health News Original
On KFF Health News’ “What the Health?,” chief Washington correspondent Julie Rovner interviewed Atul Grover of the Association of American Medical Colleges about its recent analysis showing that graduating medical students are avoiding training in states with abortion bans and major restrictions.
Biden Leans Into Health Care, Asking Voters To Trust Him Over Trump
By Phil Galewitz
May 21, 2024
KFF Health News Original
President Joe Biden’s new health care ad draws on the Affordable Care Act’s popularity among independent voters and alludes to his edge over Trump on health issues.
High Price of Popular Diabetes Drugs Deprives Low-Income People of Effective Treatment
By Renuka Rayasam
May 21, 2024
KFF Health News Original
The makers of Ozempic and Mounjaro charge list prices of around $1,000 a month for the diabetes and obesity drugs, and insurers are reluctant to pick up the tab. Often, low-income patients have to resort to less effective treatments.
Personas de bajos ingresos no pueden recibir terapias efectivas contra la diabetes por el alto costo
By Renuka Rayasam
May 21, 2024
KFF Health News Original
La escasez de suministros y las barreras que ponen las aseguradoras para obtener esta poderosa clase de medicamentos, llamados agonistas de GLP-1, han dejado a muchas personas que viven con diabetes y obesidad sin los medicamentos que necesitan para mantenerse saludables.